Summary
This prediction ended on 06.12.17 with a price of €104.50. With a performance of -6.45%, the BUY prediction for Bayer AG by Subdi closed slightly in the red. Subdi has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -0.852% | -0.852% | -48.014% | -49.185% |
iShares Core DAX® | 1.395% | -0.696% | 15.472% | 15.907% |
iShares Nasdaq 100 | 2.287% | 7.501% | 34.748% | 53.474% |
iShares Nikkei 225® | 1.617% | 2.769% | 11.442% | 8.194% |
iShares S&P 500 | 0.659% | 4.280% | 26.778% | 45.322% |
Comments by Subdi for this prediction
In the thread Bayer AG diskutieren
Subdi stimmt der Buy-Einschätzung von Subdi zu
Subdi stimmt am 27.10.2017 der Buy-Einschätzung von Subdi mit dem Kursziel 128€ zu.Überschrift: Subdi stimmt der Buy-Einschätzung von DirectorDealer_Intensive zu